Ardis Callie on Standardisation and Documentation of VTE Risk Assessments
Ardis Callie, Research Assistant, Intersection of Australian Healthcare Standards and Clinical Governance, shared on LinkedIn:
”Quality Statement 1: Standardised and documented VTE risk assessments using an agreed risk tool on admission for all patients including day cases, would be a low cost, good start to VTE prevention.
That way, chemoprophylaxis could be provided in appropriate cases.
Sadly, surgeons I know, in some private hospitals at least, assume all day cases are low risk, don’t conduct VTE risk assessments, and prioritise short term bleeding risk and ignore the consequences for the patient when they go home (despite the national VTE Prevention Clinical Care Standard 2020).
Queensland Health follows a stricter 2018 guideline so patients should be in good hands in those facilities.
Comments welcome from those in the know.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026